SEC 13F Intelligence

C Worldwide Group Holding A/S / NBIX

C Worldwide Group Holding A/S’s Neurocrine Biosciences Inc Position

Does C Worldwide Group Holding A/S own Neurocrine Biosciences Inc (NBIX)? Yes — 125.0K shares worth $16M (+0.35% of its 13F portfolio) as of Q1 2026.

Position Value
$16M
Q1 2026
Shares
125.0K
% of Portfolio
+0.35%
Quarters Held
8
currently held

Position History NBIX

Reported value by quarter
Q2 ’24: $10MQ2 ’24Q3 ’24: $11MQ3 ’24Q4 ’24: $16MQ4 ’24Q1 ’25: $13MQ1 ’25Q2 ’25: $17MQ2 ’25Q3 ’25: $18MQ3 ’25Q4 ’25: $18MQ4 ’25Q1 ’26: $16MQ1 ’26filingsflow.com
QuarterSharesValue% of Portfolio
Q1 2026125.0K$16M+0.35%
Q4 2025125.0K$18M+0.31%
Q3 2025125.0K$18M+0.27%
Q2 2025135.0K$17M+0.23%
Q1 2025115.0K$13M+0.16%
Q4 2024115.0K$16M+0.19%
Q3 202495.0K$11M+0.11%
Q2 202475.0K$10M+0.11%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See C Worldwide Group Holding A/S’s full portfolio or all institutional holders of NBIX.